Mathew Lonberg is a Hematology physician affiliated with Nyack Hospital. OpenAlex indexes 8 publications with 287 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
48.8%Kinase inhibitor15%Imbruvica34%Jakafi34%Calquence13%Cotellic11%Ibrance9%Part D<11 patientsAromatase Inhibitor14.8%Anastrozole56%Exemestane30%Letrozole15%Part D<11 patients+ 4 more classes in this area
Blood & clotting
29.1%Factor Xa inhibitor22.1%Eliquis84%Xarelto16%Part D<11 patientsVitamin K antagonist5.5%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Dermatology
7%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor7%Acyclovir100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Validation of a study design that promotes diversity in clinical trials.
Journal of Clinical Oncology
2025 - 7028 Dasatinib and docetaxel combination treatment for patients with metastatic castration-resistant prostate cancer (CRPC): analysis of Study CA180–086
European Journal of Cancer Supplements
2009 - Combined Fludarabine and Rituximab for Low Grade Lymphoma and Chronic Lymphocytic Leukemia
Leukemia & lymphoma/Leukemia and lymphoma
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”